메뉴 건너뛰기




Volumn 56, Issue 10, 2013, Pages 3866-3877

Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole- 1,4-dihydropyridines: From heart activity to brain affinity

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIETHYL 4 (6 (2,5 DIMETHOXYPHENYL)IMIDAZO[2,1 B]THIAZOL 5 YL) 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIHYDROPYRIDINE DERIVATIVE; DIMETHYL 2,6 DIMETHYL 4 (2 METHYL 6 (PYRIDIN 2 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (2 METHYL 6 (PYRIDIN 3 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (2 METHYL 6 (PYRIDIN 4 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (2 METHYL 6 (THIOPHEN 2 YL)IMIDAZO [2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (2 METHYL 6 (THIOPHEN 3 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 (PYRIDIN 2 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 (PYRIDIN 3 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 (PYRIDIN 4 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 (THIOPHEN 2 YL)IMIDAZO[2,1 B] THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 2,6 DIMETHYL 4 (6 (THIOPHEN 3 YL)IMIDAZO[2,1 B] THIAZOL 5 YL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 4 (6 (2,5 DICHLOROTHIOPHEN 3 YL) 2 METHYLIMIDAZO[2,1 B]THIAZOL 5 YL) 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; DIMETHYL 4 (6 (2,5 DICHLOROTHIOPHEN 3 YL)IMIDAZO[2,1 B]THIAZOL 5 YL) 2,6 DIMETHYL 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLATE; UNCLASSIFIED DRUG;

EID: 84878038726     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301839q     Document Type: Article
Times cited : (37)

References (29)
  • 1
    • 33644906392 scopus 로고    scopus 로고
    • L-Type calcium channels
    • Triggle, D. J. L-Type calcium channels Curr. Pharm. Des. 2006, 12, 443-457
    • (2006) Curr. Pharm. Des. , vol.12 , pp. 443-457
    • Triggle, D.J.1
  • 2
    • 29844439240 scopus 로고    scopus 로고
    • International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels
    • Catterall, W. A.; Perez-Reyes, E.; Snutch, T. P.; Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels Pharmacol. Rev. 2005, 57, 411-425
    • (2005) Pharmacol. Rev. , vol.57 , pp. 411-425
    • Catterall, W.A.1    Perez-Reyes, E.2    Snutch, T.P.3    Striessnig, J.4
  • 3
    • 79957685488 scopus 로고    scopus 로고
    • Structural and functional differences between L-type calcium channels: Crucial issues for future selective targeting
    • Zuccotti, A.; Clementi, S.; Reinbothe, T.; Torrente, A.; Vandael, D. H.; Pirone, A. Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting Trends Pharmacol. Sci. 2011, 6, 366-375
    • (2011) Trends Pharmacol. Sci. , vol.6 , pp. 366-375
    • Zuccotti, A.1    Clementi, S.2    Reinbothe, T.3    Torrente, A.4    Vandael, D.H.5    Pirone, A.6
  • 4
    • 0017432208 scopus 로고
    • Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle
    • Fleckenstein, A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle Annu. Rev. Pharmacol. Toxicol. 1977, 17, 149-166
    • (1977) Annu. Rev. Pharmacol. Toxicol. , vol.17 , pp. 149-166
    • Fleckenstein, A.1
  • 7
    • 34249049430 scopus 로고    scopus 로고
    • Calcium channel antagonists: Clinical uses - Past, present and future
    • Triggle, D. J. Calcium channel antagonists: clinical uses-past, present and future Biochem. Pharmacol. 2007, 74, 1-9
    • (2007) Biochem. Pharmacol. , vol.74 , pp. 1-9
    • Triggle, D.J.1
  • 10
    • 80054860325 scopus 로고    scopus 로고
    • 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so Far and Perspectives. Part 1: Action in Ion Channels and GPCRs
    • Ioan, P.; Carosati, E.; Micucci, M.; Cruciani, G.; Broccatelli, F.; Zhorov, B. S.; Chiarini, A.; Budriesi, R. 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far and Perspectives. Part 1: Action in Ion Channels and GPCRs Curr. Med. Chem. 2011, 18, 4901-4922
    • (2011) Curr. Med. Chem. , vol.18 , pp. 4901-4922
    • Ioan, P.1    Carosati, E.2    Micucci, M.3    Cruciani, G.4    Broccatelli, F.5    Zhorov, B.S.6    Chiarini, A.7    Budriesi, R.8
  • 11
    • 84866687385 scopus 로고    scopus 로고
    • 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, the Story so Far and Perspectives. Part 2: Action in Other Targets and Antitargets
    • Carosati, E.; Ioan, P.; Micucci, M.; Broccatelli, F.; Cruciani, G.; Zhorov, B. S.; Chiarini, A.; Budriesi, R. 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far and Perspectives. Part 2: Action in Other Targets and Antitargets Curr. Med. Chem. 2012, 19, 4306-4323
    • (2012) Curr. Med. Chem. , vol.19 , pp. 4306-4323
    • Carosati, E.1    Ioan, P.2    Micucci, M.3    Broccatelli, F.4    Cruciani, G.5    Zhorov, B.S.6    Chiarini, A.7    Budriesi, R.8
  • 14
    • 0000410045 scopus 로고
    • Hantzsch's pyridine synthesis
    • Phillips, A. P. Hantzsch's pyridine synthesis J. Am. Chem. Soc. 1949, 71, 4003-4007
    • (1949) J. Am. Chem. Soc. , vol.71 , pp. 4003-4007
    • Phillips, A.P.1
  • 15
    • 0021964049 scopus 로고
    • 6-Pyridinylimidazo[2,1- b ]thiazoles and Thiazolines as Potential Cardiotonic Agents
    • Andreani, A.; Rambaldi, M.; Andreani, F.; Bossa, R.; Galatulas, I. 6-Pyridinylimidazo[2,1- b ]thiazoles and Thiazolines as Potential Cardiotonic Agents Eur. J. Med. Chem. 1985, 20, 93-94
    • (1985) Eur. J. Med. Chem. , vol.20 , pp. 93-94
    • Andreani, A.1    Rambaldi, M.2    Andreani, F.3    Bossa, R.4    Galatulas, I.5
  • 22
    • 69449101727 scopus 로고    scopus 로고
    • GraphPad Software Inc. San Diego, CA, Accessed on 1/12/2011.
    • Motulsky, H. J. Prism 5 Statistics Guide; GraphPad Software Inc.: San Diego, CA, 2007; www.graphpad.com. Accessed on 1/12/2011.
    • (2007) Prism 5 Statistics Guide
    • Motulsky, H.J.1
  • 23
    • 84878054515 scopus 로고    scopus 로고
    • version 3.0; GraphPad Software, Inc. San Diego, CA.
    • GraphPad, version 3.0; GraphPad Software, Inc.: San Diego, CA.
    • GraphPad
  • 24
    • 72949097917 scopus 로고    scopus 로고
    • Haloperidol moderately inhibits cardiovascular L-type calcium current
    • Tarabová, B.; Nováková, M.; Lacinová, L. Haloperidol moderately inhibits cardiovascular L-type calcium current Gen. Physiol. Biophys. 2009, 28 (3) 249-529
    • (2009) Gen. Physiol. Biophys. , vol.28 , Issue.3 , pp. 249-529
    • Tarabová, B.1    Nováková, M.2    Lacinová, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.